{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:13:55Z","timestamp":1783743235162,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["420458\/2023-9"],"award-info":[{"award-number":["420458\/2023-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015800","name":"Universidade Federal de Sergipe","doi-asserted-by":"publisher","award":["408377\/2021-6"],"award-info":[{"award-number":["408377\/2021-6"]}],"id":[{"id":"10.13039\/501100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015800","name":"Universidade Federal de Sergipe","doi-asserted-by":"publisher","award":["312863\/2022-5"],"award-info":[{"award-number":["312863\/2022-5"]}],"id":[{"id":"10.13039\/501100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015800","name":"Universidade Federal de Sergipe","doi-asserted-by":"publisher","award":["310403\/2021-9"],"award-info":[{"award-number":["310403\/2021-9"]}],"id":[{"id":"10.13039\/501100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e \u00e0 Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe","doi-asserted-by":"publisher","award":["794017\/2013"],"award-info":[{"award-number":["794017\/2013"]}],"id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e \u00e0 Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe","doi-asserted-by":"publisher","award":["019203.04917\/2023-5"],"award-info":[{"award-number":["019203.04917\/2023-5"]}],"id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/11559-0"],"award-info":[{"award-number":["2023\/11559-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pbb.2026.174219","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:55:02Z","timestamp":1780530902000},"page":"174219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease"],"prefix":"10.1016","volume":"266","author":[{"given":"Clarissa G.A.","family":"Alvaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyana C.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylaine S.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o E.C.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.M.","family":"Bispo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abra\u00e3o J.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.M.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina H.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katty A.A.L.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auderlan M.","family":"Gois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2026.174219_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0278-5846(02)00340-8","article-title":"Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione\/reduced glutathione ratio (GSSG\/GSH) enhancement in rats","volume":"27","author":"Ab\u00edlio","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174219_bb0010","first-page":"AF01","article-title":"Selective serotonin re-uptake inhibitors (SSRIs) induced weight changes: a dose and duration dependent study on albino rats","volume":"10","author":"Aggarwal","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"issue":"3","key":"10.1016\/j.pbb.2026.174219_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/S0004-282X1987000300001","article-title":"Rem sleep deprivation in an experimental model of Parkinson\u2019s disease","volume":"45","author":"Andrade","year":"1987","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"10.1016\/j.pbb.2026.174219_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59081454","article-title":"Pharmacological and non-pharmacological treatments for depression in Parkinson\u2019s disease: an updated review","volume":"59","author":"Angelopoulou","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.pbb.2026.174219_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131709","article-title":"Differential rearing alters forced swim test behavior, fluoxetine efficacy, and post-test weight gain in male rats","volume":"10","author":"Arndt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2026.174219_bb0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1590\/1415-4714.2016v19n1p114.9","article-title":"Introdu\u00e7\u00e3o \u00e0 \u201cParalisia agitante\u201d, de James Parkinson (1817)","volume":"19","author":"Berrios","year":"2016","journal-title":"Rev. Latinoam. Psicopatol. Fundam."},{"key":"10.1016\/j.pbb.2026.174219_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson\u2019s disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.2042-7158.1971.tb09907.x","article-title":"Effect of calcium on reserpine-induced catalepsy","volume":"23","author":"Boyaner","year":"1971","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2026.174219_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2026.174219_bb0050","article-title":"Psicofarmacoterapia","volume":"22","author":"Brasil","year":"2000","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174219_bb0055","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"31","author":"Broen","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2026.174219_bb0060","series-title":"Psychopharmacology Influence of Dose and Route of Administration on the Kinetics of Fluoxetine and its Metabolite Norfluoxetine in the Rat","first-page":"509","author":"Caccia","year":"1990"},{"key":"10.1016\/j.pbb.2026.174219_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0215277","article-title":"Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins","volume":"14","author":"Callizot","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2026.174219_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00415-008-5006-1","article-title":"Early Parkinson\u2019s disease and non-motor issues","volume":"255","author":"Chaudhuri","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11910-005-0072-6","article-title":"The non-motor symptom complex of Parkinson\u2019s disease: a comprehensive assessment is essential","volume":"5","author":"Chaudhuri","year":"2005","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.pbb.2026.174219_bb0085","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pbb.2026.174219_bb0090","author":"Cheung"},{"issue":"8","key":"10.1016\/j.pbb.2026.174219_bb0095","article-title":"Depression in Parkinson\u2019s disease: a narrative review","volume":"14","author":"Chikatimalla","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pbb.2026.174219_bb0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuroscience.2017.07.031","article-title":"Exercise in an animal model of Parkinson\u2019s disease: motor recovery but not restoration of the nigrostriatal pathway","volume":"359","author":"Churchill","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2026.174219_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson\u2019s disease: a systematic review and meta-analysis of 129 studies","volume":"141","author":"Cong","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2026.174219_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.923957","article-title":"Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats","volume":"16","author":"Cunha","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2026.174219_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","article-title":"Glutathione peroxidase, glial cells and Parkinson's disease","volume":"52","author":"Damier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2026.174219_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.18679\/CN11-6030_R.2016.019","article-title":"Antiparkinsonian treatment for depression in Parkinson\u2019s disease: are selective serotonin reuptake inhibitors recommended?","volume":"2","author":"De Deurwaerd\u00e8re","year":"2016","journal-title":"Transl. Neurosci. Clin."},{"key":"10.1016\/j.pbb.2026.174219_bb0130","series-title":"Int. Rev. Neurobiol.","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/bs.irn.2017.05.033","article-title":"Sleep dysfunction in Parkinson\u2019s disease","author":"Falup-Pecurariu","year":"2017"},{"key":"10.1016\/j.pbb.2026.174219_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","article-title":"Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease","volume":"231","author":"Fernandes","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2026.174219_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-015-4118-4","article-title":"Behavioral and neurochemical effects induced by reserpine in mice","volume":"233","author":"Freitas","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174219_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mds.28340","article-title":"Serotonergic system impacts levodopa response in early Parkinson\u2019s and future risk of dyskinesia","volume":"36","author":"Fu","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2026.174219_bb0145","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pbb.2026.174219_bb0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174219_bb0155","article-title":"\u03b2-2 agonist and antagonist adrenoceptors induce neuroprotection in a progressive model of parkinsonism","volume":"271","author":"Gois","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2026.174219_bb0160","article-title":"Cognitive impairment in Parkinson\u2019s disease: epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav. Sci. (Basel)"},{"key":"10.1016\/j.pbb.2026.174219_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2016.00293","article-title":"Early degeneration of both dopaminergic and serotonergic axons \u2013 a common mechanism in Parkinson\u2019s disease","volume":"10","author":"Grosch","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pbb.2026.174219_bb0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/brain\/awae072","article-title":"Cholinergic and noradrenergic aspects of Parkinson\u2019s disease","volume":"147","author":"Husain","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2026.174219_bb0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-007-1030-6","article-title":"The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson\u2019s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram","volume":"197","author":"Kuan","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2026.174219_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2016.00283","article-title":"Commentary: evaluation of models of Parkinson\u2019s disease","volume":"10","author":"Leal","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2026.174219_bb0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchemneu.2018.12.011","article-title":"Serotonergic dysfunction in a model of parkinsonism induced by reserpine","volume":"96","author":"Leal","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pbb.2026.174219_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainresbull.2019.01.009","article-title":"Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism","volume":"146","author":"Leal","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2026.174219_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2017.00078","article-title":"Spontaneously hypertensive rats (SHR) are resistant to a reserpine-induced progressive model of Parkinson\u2019s disease: differences in motor behavior, tyrosine hydroxylase and \u03b1-synuclein expression","volume":"9","author":"Le\u00e3o","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pbb.2026.174219_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art","volume":"84","author":"Leite Silva","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.pbb.2026.174219_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/187152712800792839","article-title":"Paradoxical sleep deprivation modulates tyrosine hydroxylase expression in the nigrostriatal pathway and attenuates motor deficits induced by dopaminergic depletion","volume":"11","author":"Lima","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.pbb.2026.174219_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2018.01.017","article-title":"Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine","volume":"139","author":"Lins","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2026.174219_bb0215","article-title":"Comparative efficacy and acceptability of antidepressants in Parkinson\u2019s disease: a network meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.pbb.2026.174219_bb0220","first-page":"1","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2026.174219_bb0225","first-page":"149","article-title":"Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats","volume":"2","author":"Mahmoudi","year":"2012","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.pbb.2026.174219_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2018.2820","article-title":"Patterns of dementia treatment and frank prescribing errors in older adults with Parkinson disease","volume":"76","author":"Mantri","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09540260020002532","article-title":"Anxiety disorders in Parkinson\u2019s disease","volume":"12","author":"Marsh","year":"2000","journal-title":"Int. Rev. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2026.174219_bb0240","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"Mcgeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2026.174219_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2022.102162","article-title":"Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism","volume":"125","author":"Melo","year":"2022","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.pbb.2026.174219_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108415","article-title":"Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinso\u0144s disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity","volume":"102","author":"Mendon\u00e7a","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pbb.2026.174219_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bramec.2025.202485","article-title":"Patterns of BDNF expression in the dorsal striatum and cognitive processing areas during aging in a progressive model of parkinsonism","volume":"144","author":"Mendon\u00e7a","year":"2025","journal-title":"Brain Mech."},{"key":"10.1016\/j.pbb.2026.174219_bb0260","doi-asserted-by":"crossref","first-page":"15742","DOI":"10.1523\/JNEUROSCI.2989-11.2011","article-title":"Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction","volume":"31","author":"Morelli","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2026.174219_bb0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/joor.12030","article-title":"Changes in activity and structure of jaw muscles in Parkinson\u2019s disease model rats","volume":"40","author":"Nakamura","year":"2013","journal-title":"J. Oral Rehabil."},{"key":"10.1016\/j.pbb.2026.174219_bb0270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2015.09.005","article-title":"New insight into the therapeutic role of the serotonergic system in Parkinson\u2019s disease","volume":"134","author":"Ohno","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2026.174219_bb5000","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.pbb.2026.174219_bb0275","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nrl.2016.02.002","article-title":"Antidepressants in Parkinson\u2019s disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid","volume":"33","author":"Pe\u00f1a","year":"2018","journal-title":"Neurologia"},{"issue":"Suppl. 2","key":"10.1016\/j.pbb.2026.174219_bb0280","first-page":"II25","article-title":"Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson\u2019s disease","volume":"247","author":"Plaitakis","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0285","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/npp.2015.69","article-title":"Fluoxetine administration exacerbates oral tremor and striatal dopamine depletion in a rodent pharmacological model of parkinsonism","volume":"40","author":"Podurgiel","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"21","key":"10.1016\/j.pbb.2026.174219_bb0290","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","article-title":"Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures","volume":"75","author":"Politis","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2026.174219_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-10-6","article-title":"Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson\u2019s disease with severe neurodegeneration","volume":"10","author":"Pothakos","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.pbb.2026.174219_bb0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cger.2019.09.012","article-title":"Depression and anxiety in Parkinson disease","volume":"36","author":"Ray","year":"2020","journal-title":"Clin. Geriatr. Med."},{"issue":"1","key":"10.1016\/j.pbb.2026.174219_bb0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(95)00164-6","article-title":"Vacuous jaw movements in rats induced by acute reserpine and low-dose apomor-phine administration: possible model of parkinsonian tremor","volume":"53","author":"Salamone","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2026.174219_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.115042","article-title":"Motor impairments and increased GFAP expression in different stages of a progressive model of parkinsonism induced by reserpine","volume":"300","author":"Santos","year":"2025","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2026.174219_bb0315","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbr.2013.06.031","article-title":"Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine","volume":"253","author":"Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2026.174219_bb0320","first-page":"1","article-title":"Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats","volume":"145","author":"Santos","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pbb.2026.174219_bb0325","doi-asserted-by":"crossref","first-page":"491","DOI":"10.15171\/apb.2015.067","article-title":"Effect of buspirone, fluoxetine and 8-OH-DPAT on striatal expression of bax, caspase-3 and Bcl-2 proteins in 6-hydroxydopamine-induced hemi-parkinsonian rats","volume":"5","author":"Sharifi","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.pbb.2026.174219_bb0330","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/mds.870110517","article-title":"Fluoxetine in Parkinson\u2019s disease","volume":"11","author":"Simons","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2026.174219_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-10-49","article-title":"Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson\u2019s disease: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Skapinakis","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0340","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.13.2.187","article-title":"Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson\u2019s disease","volume":"13","author":"Slaughter","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.pbb.2026.174219_bb0345","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(97)01271-5","article-title":"Acute reserpine administration elicits long-term spontaneous oral dyskinesia","volume":"337","author":"Sussman","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174219_bb0350","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pnpbp.2012.04.008","article-title":"Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders","volume":"38","author":"Tatara","year":"2012","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2026.174219_bb0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.616","article-title":"Weight loss in the early stage of progressive supranuclear palsy","volume":"7","author":"Tsuge","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.pbb.2026.174219_bb0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.05.012","article-title":"Association of low serum BDNF with depression in patients with Parkinson\u2019s disease","volume":"41","author":"Wang","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.pbb.2026.174219_bb0370","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.expneurol.2009.07.013","article-title":"Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model","volume":"219","author":"Winner","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2026.174219_bb0375","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41586-023-06926-4","article-title":"Transport and inhibition mechanisms of human VMAT2","volume":"626","author":"Wu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2026.174219_bb0380","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-017-0736-z","article-title":"Depression and anxiety behaviour in a rat model of chronic migraine","volume":"18","author":"Zhang","year":"2017","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.pbb.2026.174219_bb0385","first-page":"1075","article-title":"Nonmotor symptoms in patients with Parkinson disease","volume":"148","author":"Zhang","year":"2016","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.pbb.2026.174219_bb0390","article-title":"Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis","volume":"96","author":"Zhuo","year":"2017","journal-title":"Medicine (United States)"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:59:49Z","timestamp":1783742389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305726000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":79,"alternative-id":["S0091305726000742"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174219","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174219"}}